Company passed the audit ICH GCP E6 (R2)
02 October 2018
In October 2018, our company passed the audit to confirm compliance of clinical research practice with the appropriate ICH GCP E6 (R2) requirements and Ethical Principles.
The purpose of the audit was to assess the compliance of clinical research practice with the appropriate ICH/GCP requirements and Ethical Principles.
The audit performed in PHARMBIOTEST confirmed compliance of clinical research practice with the appropriate ICH GCP E6 (R2) requirements and Ethical Principles for Medical Research Involving Human Subjects – Declaration of Helsinki.